This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Black Ant

Starting date:
November 24, 2012
Posting date:
December 10, 2012
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Undeclared Substance, Product Safety
Audience:
General Public (GP), Healthcare Professionals, Hospitals
Identification number:
RA-16123

Recalled Products

A. Black Ant

Reason

Health Canada’s testing identified undeclared Sildenafil, a prescription drug. The product is not authorized for sale in Canada.
 

Depth of distribution

Wholesalers and pharmacies (retail and hospital) across Canada.

Affected products

A. Black Ant

DIN, NPN, DIN-HIM
N/A
Dosage form

Capsule

Strength

4600 mg

Lot or serial number

Jian Jin (2006) No. (3627878)

All other lots

Companies
Recalling Firm
DVDXPRO
Marketing Authorization Holder
N/A

Date modified: